$YHGJ

YUNHONG GREEN CTI LTD.

CIK:0001042187|SEC Filings

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 3,900,000	$ 5,457,000	$ 10,054,000	$ 10,259,000
Cost of sales	3,362,000	4,479,000	8,502,000	8,415,000
Gross profit	538,000	978,000	1,552,000	1,844,000
Operating expenses:
General and administrative	675,000	754,000	1,598,000	1,593,000
Selling	34,000	37,000	71,000	72,000
Advertising and marketing	149,000	168,000	302,000	338,000
Total operating expenses	858,000	959,000	1,971,000	2,003,000
Income (loss) from operations	(320,000)	19,000	(419,000)	(159,000)
Other (expense) income:
Interest expense	(225,000)	(227,000)	(467,000)	(465,000)
Other income/(expense)	2,000	23,000	2,000	23,000
Total other expense, net	(223,000)	(204,000)	(465,000)	(442,000)
Net loss	(543,000)	(185,000)	(884,000)	(601,000)
Deemed dividends on preferred stock	(43,000)	(43,000)	(86,000)	(86,000)
Net loss attributable to common shareholders	$ (586,000)	$ (228,000)	$ (970,000)	$ (687,000)
Basic income (loss) per common share	$ (0.22)	$ (0.09)	$ (0.37)	$ (0.26)
Diluted income (loss) per common share	$ (0.22)	$ (0.09)	$ (0.37)	$ (0.26)
Weighted average number of shares and equivalent shares of common stock outstanding:
Basic	2,608,638	2,608,082	2,604,856	2,608,082
Diluted	2,608,638	2,608,082	2,604,856	2,608,082

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (884,000)	$ (601,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	286,000	322,000
Equity compensation expense	51,000	17,000
Change in assets and liabilities:
Accounts receivable	2,660,000	1,608,000
Inventories	911,000	313,000
Prepaid expenses and other assets	(68,000)	169,000
Trade payables	(195,000)	(104,000)
Operating leases	22,000	40,000
Advance investor deposit	75,000
Accrued liabilities	(323,000)	(50,000)
Net cash (used in) provided by operating activities	2,535,000	1,714,000
Cash flows from investing activities:
Purchases of property, plant and equipment	(30,000)	(42,000)
Net cash (used in) provided by investing activities	(30,000)	(42,000)
Cash flows from financing activities:
Repayment of note payable	(51,000)	(42,000)
Net repayments on revolving line of credit	(2,231,000)	(1,832,000)
Net cash provided by (used in) financing activities	(2,282,000)	(1,874,000)
Net increase (decrease) in cash and cash equivalents	223,000	(202,000)
Cash and cash equivalents at beginning of period	97,000	220,000
Cash and cash equivalents at end of period	320,000	18,000
Supplemental disclosure of cash flow information and noncash investing and financing activities:
Cash payments for interest	467,000	465,000
Accretion of dividends on preferred stock	86,000	86,000
Conversion of advance received from investors into common stock		1,050,000
Common stock issued in exchange for rent due to Icy Mellon		$ 182,000

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 320,000	$ 97,000
Accounts receivable, net	3,295,000	5,955,000
Inventories	7,827,000	8,738,000
Prepaid expenses	351,000	283,000
Total current assets	11,793,000	15,073,000
Property, plant and equipment:
Machinery and equipment	21,993,000	21,993,000
Office furniture and equipment	2,122,000	2,122,000
Intellectual property	783,000	783,000
Leasehold improvements	39,000	39,000
Fixtures and equipment	518,000	518,000
Projects under construction	170,000	140,000
Property, plant and equipment gross	25,625,000	25,595,000
Less: accumulated depreciation and amortization	(21,885,000)	(21,599,000)
Total property, plant and equipment, net	3,740,000	3,996,000
Other assets:
Operating lease right-of-use	3,087,000	3,393,000
Total other assets	3,087,000	3,393,000
TOTAL ASSETS	18,620,000	22,462,000
Current liabilities:
Trade payables	1,482,000	1,677,000
Line of credit	4,591,000	6,822,000
Operating lease liabilities – current portion	659,000	596,000
Advance investor deposits	225,000	150,000
Accrued liabilities	627,000	950,000
Total current liabilities	8,371,000	10,685,000
Long-term liabilities:
Notes payable – net of current portion		348,000
Operating lease liabilities – noncurrent	2,526,000	2,873,000
Total long-term liabilities	2,526,000	3,221,000
TOTAL LIABILITIES	10,897,000	13,906,000
SHAREHOLDERS’ EQUITY
Common stock - no par value, 2,000,000,000 shares authorized, 2,613,670 and 2,601,788 shares issued and 2,609,244 and 2,597,362 shares outstanding at June 30, 2026 and December 31, 2025, respectively	27,891,000	27,891,000
Additional paid-in-capital	7,676,000	7,711,000
Accumulated deficit	(29,270,000)	(28,386,000)
Less: Treasury stock, 4,426 shares, at cost	(161,000)	(161,000)
TOTAL SHAREHOLDERS’ EQUITY	7,723,000	8,556,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	18,620,000	22,462,000
Series E Preferred Stock [Member]
SHAREHOLDERS’ EQUITY
Preferred stock, value	1,032,000	976,000
Series F Preferred Stock [Member]
SHAREHOLDERS’ EQUITY
Preferred stock, value	555,000	525,000
Nonrelated Party [Member]
Current liabilities:
Notes payable	443,000	146,000
Related Party [Member]
Current liabilities:
Notes payable	$ 344,000	$ 344,000